The α7 nAChR agonist AR-R17779 emerged as the most effective treatment, able to attenuate colitis severity and to revert the rise in splenic T-cells populations and in colonic inflammatory cytokines levels induced by haptenization. The gene discussed is CHRNA7; the disease is colitis.